BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32345066)

  • 1. The emerging role of computational design in peptide macrocycle drug discovery.
    Mulligan VK
    Expert Opin Drug Discov; 2020 Jul; 15(7):833-852. PubMed ID: 32345066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead discovery and optimization strategies for peptide macrocycles.
    Bhat A; Roberts LR; Dwyer JJ
    Eur J Med Chem; 2015 Apr; 94():471-9. PubMed ID: 25109255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-Based Macrocycle Design in Small-Molecule Drug Discovery and Simple Metrics To Identify Opportunities for Macrocyclization of Small-Molecule Ligands.
    Cummings MD; Sekharan S
    J Med Chem; 2019 Aug; 62(15):6843-6853. PubMed ID: 30860377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling the binding mode of macrocycles: Docking and conformational sampling.
    Martin SJ; Chen IJ; Chan AWE; Foloppe N
    Bioorg Med Chem; 2020 Jan; 28(1):115143. PubMed ID: 31771798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tackling the conformational sampling of larger flexible compounds and macrocycles in pharmacology and drug discovery.
    Chen IJ; Foloppe N
    Bioorg Med Chem; 2013 Dec; 21(24):7898-920. PubMed ID: 24184215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex macrocycle exploration: parallel, heuristic, and constraint-based conformer generation using ForceGen.
    Jain AN; Cleves AE; Gao Q; Wang X; Liu Y; Sherer EC; Reibarkh MY
    J Comput Aided Mol Des; 2019 Jun; 33(6):531-558. PubMed ID: 31054028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive computational design of ordered peptide macrocycles.
    Hosseinzadeh P; Bhardwaj G; Mulligan VK; Shortridge MD; Craven TW; Pardo-Avila F; Rettie SA; Kim DE; Silva DA; Ibrahim YM; Webb IK; Cort JR; Adkins JN; Varani G; Baker D
    Science; 2017 Dec; 358(6369):1461-1466. PubMed ID: 29242347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrocycles and macrocyclization in anticancer drug discovery: Important pieces of the puzzle.
    Zhang C; Liu F; Zhang Y; Song C
    Eur J Med Chem; 2024 Mar; 268():116234. PubMed ID: 38401189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grabbing for the ring: macrocycles tweak the conventions of drug making.
    Wolfson W
    Chem Biol; 2012 Nov; 19(11):1356-7. PubMed ID: 23177189
    [No Abstract]   [Full Text] [Related]  

  • 10. Protein epitope mimetic macrocycles as biopharmaceuticals.
    Luther A; Moehle K; Chevalier E; Dale G; Obrecht D
    Curr Opin Chem Biol; 2017 Jun; 38():45-51. PubMed ID: 28319811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformationally based design of macrocycles as antitumor agents.
    Singh EK; Sellers RP; Alexander LD; McAlpine SR
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):544-52. PubMed ID: 18600570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting bioactive conformations and binding modes of macrocycles.
    Anighoro A; de la Vega de León A; Bajorath J
    J Comput Aided Mol Des; 2016 Oct; 30(10):841-849. PubMed ID: 27655412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of peptide-based macrocyclic cyclophilin inhibitors.
    Granger BA; Brown DG
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5304-5307. PubMed ID: 27687672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational analysis of macrocycles: comparing general and specialized methods.
    Olanders G; Alogheli H; Brandt P; Karlén A
    J Comput Aided Mol Des; 2020 Mar; 34(3):231-252. PubMed ID: 31965404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Endocyclic Control Elements for Peptide Macrocycles.
    Appavoo SD; Kaji T; Frost JR; Scully CCG; Yudin AK
    J Am Chem Soc; 2018 Jul; 140(28):8763-8770. PubMed ID: 29920073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the unpredictable: Recent structure-activity studies on peptide-based macrocycles.
    Wahyudi H; McAlpine SR
    Bioorg Chem; 2015 Jun; 60():74-97. PubMed ID: 25973779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties?
    Giordanetto F; Kihlberg J
    J Med Chem; 2014 Jan; 57(2):278-95. PubMed ID: 24044773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and optimization of peptide macrocycles.
    White AM; Craik DJ
    Expert Opin Drug Discov; 2016 Dec; 11(12):1151-1163. PubMed ID: 27718641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrocyclic α helical peptide therapeutic modality: A perspective of learnings and challenges.
    Sawyer TK; Partridge AW; Kaan HYK; Juang YC; Lim S; Johannes C; Yuen TY; Verma C; Kannan S; Aronica P; Tan YS; Sherborne B; Ha S; Hochman J; Chen S; Surdi L; Peier A; Sauvagnat B; Dandliker PJ; Brown CJ; Ng S; Ferrer F; Lane DP
    Bioorg Med Chem; 2018 Jun; 26(10):2807-2815. PubMed ID: 29598901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Site Saturation Mutagenesis of Canonical and Non-Canonical Amino Acids to Probe Protein-Peptide Interactions.
    Holden JK; Pavlovicz R; Gobbi A; Song Y; Cunningham CN
    Front Mol Biosci; 2022; 9():848689. PubMed ID: 35495632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.